Results 161 to 170 of about 27,357 (215)

Antifungal Susceptibility Profile of Aspergillus Strains Isolated From the Lower Respiratory Tract in Eastern Indian Patients: A Hospital-Based Study. [PDF]

Microbiologyopen
Nikhil A, Choudhury S, Bhatia M, Tiwari AK, Srivastava R, Prasad A, Tilak R, Gupta MK, Narayan RJ.   +8 more
europepmc   +1 more source

Epidemiology of Fungal Bloodstream Infections and Antifungal Susceptibility in a Tertiary Care Hospital in Riyadh, Saudi Arabia: A Rare <i>Candida</i> Co-Infection Case. [PDF]

Pathogens
Banawas SS.
europepmc   +1 more source

Antifungal and fungicide susceptibility of clinical, animal, and environmental Fusarium and Neocosmospora species from Colombia: a one-health approach. [PDF]

Sci Rep
Saenz V, Lizcano-Salas AF, Le Pape P, Celis Ramírez AM.   +3 more
europepmc   +1 more source

Pharmacovigilance insights: safety profiles of antifungal agents for invasive aspergillosis. [PDF]

Front Pharmacol
Jia W, Wang T, Wang J.
europepmc   +1 more source

The Impact of Genetic Polymorphisms on the Clinical Efficacy of Azole Antifungals. [PDF]

Genes (Basel)
Singam H, Mossad S.
europepmc   +1 more source

<i>Aspergillus calidoustus</i>: An Emerging Cause of Invasive Aspergillosis and the Role of Metagenomic Next-Generation Sequencing Test in Its Diagnosis. [PDF]

Case Rep Infect Dis
Chatterjee T, Roy M, Almoujahed MO, Ahmad S.   +3 more
europepmc   +1 more source

Phaeohyphomycoses in kidney transplant recipients: A 10-year retrospective study from the French West Indies. [PDF]

Med Mycol
Thomas C, Boullé C, Claude PA, Claudeon J, Cossard Y, Devatine S, Antonowicz J, Nicolas M, Amarsy R, Markowicz S, Coussement J, Schepers K, Haboub M, Musson P, Piednoir P, Lanternier F, Epelboin L, Hermoso DG, Tardieu L.   +18 more
europepmc   +1 more source

Comparative study of liposomal amphotericin B, posaconazole, and micafungin for primary antifungal prophylaxis in pediatric patients with acute leukemia. [PDF]

J Cancer Res Clin Oncol
Gottschlich AS, Ernst J, Milde T, Gruhn B.   +3 more
europepmc   +1 more source

Physiologically-based pharmacokinetic model for predicting drug-drug interactions perpetrated by posaconazole in healthy subjects with normal weight and obesity: Concomitant use and washout. [PDF]

J Pharmacokinet Pharmacodyn
Bruno CD, Elmokadem A, Greenblatt DJ, Chow CR.   +3 more
europepmc   +1 more source

In vitro evaluation of olorofim and antifungal combinations against Aspergillus and Candida species. [PDF]

J Antimicrob Chemother
Pinder C, Lebedinec R, Oliver JD, Birch M, Law D.   +4 more
europepmc   +1 more source